Analyst Expectations for Unicycive Therapeutics's Future
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for Unicycive Therapeutics (NASDAQ:UNCY) within the last quarter. According to 8 analysts offering 12-month price targets in the last 3 months, Unicycive Therapeutics has an average price target of $5.75, a decrease of 45.24% from the previous average price target of $10.50.
July 19, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have provided bullish ratings for Unicycive Therapeutics, with a decreased average price target.
While analysts are bullish on Unicycive Therapeutics, the decrease in the average price target could indicate a potential downside. However, the overall bullish sentiment could balance this out, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100